Calcified Tissue International

, Volume 33, Issue 1, pp 285–286 | Cite as

Effect of sodium etidronate and phenytoin on pagetic bone

  • H. M. PerryIII
  • Louis V. Avioli


Sodium Etidronate Pagetic Bone Sodium Etidronate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Hahn, T. J., Hendin, B. A., Scharp, C. R., Boisseau, V. C., Haddad, J. G.: Serum 25-hydroxycalciferol levels and bone mass in children on chronic anticonvulsant therapy, N. Engl. J. Med.292:550–554, 1975CrossRefGoogle Scholar
  2. 2.
    Hill, L. F., Lumb, G. A., Mawer, E. B., Stanbury, S. W.: Indirect inhibition of the biosynthesis of 1,25 dihydroxycholecalciferol in rats treated with a diphosphonate, Clin. Sci.44, 335–347, 1973PubMedGoogle Scholar
  3. 3.
    Khairi, M. R. A., Altman, R. D., DeRosa, G. P., Zimmermann, J., Schenk, R. K., Johnston, C. C.: Sodium etidronate in the treatment of Paget's disease of bone, Ann. Intern. Med.87:656–663, 1977PubMedGoogle Scholar
  4. 4.
    DeRose, J., Singer, F. R., Avramides, A., Flores, A., Dziadiw, R., Baker, R. K., Wallach, S.: Response of Paget's disease to porcine and salmon calcitonins, Am. J. Med.56:858–866, 1974CrossRefPubMedGoogle Scholar
  5. 5.
    Plasmans, C. M. T., Jap, P. H. K., Kuijpers, W., Slooff, T. J. J. H.: Influence of a diphosphonate on the cellular aspect of young bone tissue, Calcif. Tissue Int.32, 247–256, 1980PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1981

Authors and Affiliations

  • H. M. PerryIII
    • 1
  • Louis V. Avioli
    • 1
  1. 1.Washington University of Medicine, The Jewish Hospital of St. LouisSt. LouisUSA

Personalised recommendations